Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00151476 · ClinicalTrials.gov registry record
Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients
A clinical trial, sponsored by Pfizer.
- Terminated
- Registry status
- 68
- Enrollment target
NCT00151476: Clinical Trial study, sponsored by Pfizer.
NCT00151476 is a clinical trial that was terminated before completion, run by Pfizer. The registered enrollment target is 68 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00151476 was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- 68 participants
- Enrollment target
Study Summary
This is a registry-based observational study assessing clinical outcomes in FAP patients receiving celecoxib compared with historical/concurrent registry patients who have not received celecoxib. Both retrospective and prospective data will be utilized. No sampling methods apply.
Primary Outcome
Time(months): \[date of first excisional polypectomy of rectal polyp post IRA minus date of prior IRA plus 1\] divided by 30.44. Baseline = start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and comparable to index date for control subjects. Index date calculated as Matched Celecoxib-treated patients: number of days from most recent FAP-related surgery (IRA or IPAA) to start of study follow-up; add this number of days to matched control patient'
Interventions
- DRUG Celecoxib
- OTHER Routine Medical Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2004-11 |
| Est. Completion | 2008-11 |
Why NCT00151476 stopped before completion
NCT00151476 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 68 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Celecoxib is the first listed.
NCT00151476 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00151476 about?
NCT00151476 is a clinical study titled "Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients". This is a registry-based observational study assessing clinical outcomes in FAP patients receiving celecoxib compared with historical/concurrent registry patients who have not received celecoxib. Both retrospective and prospective data will be utilized. No sampling methods apply.
What is the current status of trial NCT00151476?
This trial is currently terminated. The enrollment target is 68 participants. The study started on 2004-11. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00151476?
The interventions under investigation include: Celecoxib (DRUG), Routine Medical Care (OTHER).
Who is sponsoring clinical trial NCT00151476?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia